⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for neuromuscular

Every month we try and update this database with for neuromuscular cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Exploring Outcomes and Characteristics of Myasthenia Gravis 2NCT06002945
Myasthenia Grav...
Blood sample
18 Years - Yale University
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia GravisNCT05917184
Myasthenia Grav...
Telehealth
18 Years - Yale University
Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic SyndromeNCT02189720
Congenital Myas...
Lambert-Eaton M...
Nystagmus, Acqu...
Amifampridine P...
2 Years - Catalyst Pharmaceuticals, Inc.
Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic SyndromeNCT02189720
Congenital Myas...
Lambert-Eaton M...
Nystagmus, Acqu...
Amifampridine P...
2 Years - Catalyst Pharmaceuticals, Inc.
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia GravisNCT06359041
Generalized Mya...
CABA-201
18 Years - 70 YearsCabaletta Bio
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: